Monterey Bio Acquisition in a preliminary proxy filing outlines a proposed merger deadline extension into 2023. The current deadline is Oct. 5.
The biotech-focused SPAC raised $115 million in an October 2021 IPO.
The SPAC is led by CEO Sanjeev Satyal, Ph.D., From 2018 to February 2021, Dr. Satyal served as CEO of pH Pharma Co. Inc., a clinical-stage biopharmaceutical company. Read more.
